The story lands roughly two years after OpenAI CEO Sam Altman publicly predicted that AI would eventually enable a single person to build a billion-dollar company. In this landscape, Medvi has emerged as a significant player in the telehealth sector, specializing in GLP-1 treatments.
Founded by Matthew Gallagher, Medvi has seen remarkable growth since opening its doors in September 2024. With an initial investment of just $20,000 and the aid of over a dozen AI tools, Gallagher has built a company that reached $401 million in sales in 2025 and is projected to soar to $1.8 billion in 2026.
By the end of 2025, Medvi had attracted 250,000 customers, a testament to its innovative approach and strategic partnerships with organizations like CareValidate and OpenLoop Health. Gallagher’s brother, Elliot, serves as the company’s sole employee, highlighting the ultra-lean model that has become a hallmark of Medvi’s operations.
In February 2026, Medvi launched a men’s health line, which quickly gained traction, reaching 50,000 customers in its first month. This rapid uptake reflects the growing demand for accessible health solutions tailored to men, further solidifying Medvi’s position in the market.
Gallagher expressed his excitement about the company’s trajectory, stating, “growth was insane.” This sentiment is echoed by industry observers, who note that Medvi’s success is proof that AI is enabling ultra-lean, hyper-scalable companies.
As Medvi continues to expand its offerings, including a focus on men’s health, the company is poised to redefine the telehealth landscape. With a net profit margin of 16.2% in 2025, the financial health of the company appears robust, suggesting a promising future ahead.
Industry experts, including Jon Lensing, have remarked on Gallagher’s unique ability to leverage AI, saying, “Matthew’s native tongue seems to be A.I.” This innovative spirit is driving Medvi’s growth and positioning it as a leader in the telehealth space.
Looking ahead, observers anticipate that Medvi will continue to innovate and expand its customer base, potentially reshaping how healthcare is delivered in a digital age. As the company navigates this exciting phase, its journey serves as a compelling case study in the intersection of technology and healthcare.
You may also like
